Business Description
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US92407M2061
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician's independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.18 | |||||
| Equity-to-Asset | -0.08 | |||||
| Debt-to-Equity | -3.55 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -86.5 | |||||
| Beneish M-Score | -1.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 567.6 | |||||
| 3-Year EBITDA Growth Rate | -598.4 | |||||
| 3-Year EPS without NRI Growth Rate | -597.3 | |||||
| 3-Year FCF Growth Rate | -633.2 | |||||
| 3-Year Book Growth Rate | -14.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.63 | |||||
| 9-Day RSI | 31.85 | |||||
| 14-Day RSI | 33.3 | |||||
| 6-1 Month Momentum % | 47.04 | |||||
| 12-1 Month Momentum % | -13.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 0.99 | |||||
| Days Inventory | 27.61 | |||||
| Days Sales Outstanding | 57.5 | |||||
| Days Payable | 114.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.6 | |||||
| Shareholder Yield % | 1.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.62 | |||||
| Operating Margin % | -210.28 | |||||
| Net Margin % | -192.67 | |||||
| FCF Margin % | -213.64 | |||||
| ROE % | -496.74 | |||||
| ROA % | -127.77 | |||||
| ROIC % | -1059.11 | |||||
| ROC (Joel Greenblatt) % | -2985.12 | |||||
| ROCE % | -251.24 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.14 | |||||
| EV-to-EBIT | -1.5 | |||||
| EV-to-EBITDA | -1.52 | |||||
| EV-to-Revenue | 3.28 | |||||
| EV-to-Forward-Revenue | 1.53 | |||||
| EV-to-FCF | -1.54 | |||||
| Price-to-Median-PS-Value | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -66.67 | |||||
| FCF Yield % | -57.04 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AWH
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.177 | ||
| EPS (TTM) ($) | -2.09 | ||
| Beta | 1.86 | ||
| Volatility % | 118.38 | ||
| 14-Day RSI | 33.3 | ||
| 14-Day ATR ($) | 0.35624 | ||
| 20-Day SMA ($) | 3.70725 | ||
| 12-1 Month Momentum % | -13.08 | ||
| 52-Week Range ($) | 2.3087 - 9.599999 | ||
| Shares Outstanding (Mil) | 10.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Womens Health Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(AWH)'s stock price today?
The current price of AWH is $3.33. The 52 week high of AWH is $9.60 and 52 week low is $2.31.
When is next earnings date of Aspira Womens Health Inc(AWH)?
The next earnings date of Aspira Womens Health Inc(AWH) is 2024-03-22 Est..
Does Aspira Womens Health Inc(AWH) pay dividends? If so, how much?
Aspira Womens Health Inc(AWH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers